Properties and applications of embryonic stem cells

Mouse embryonic stem (ES) cells are pluripotent cells derived from the early embryo and can be propagated stably in undifferentiated state in vitro. They retain the ability to differentiate into all cell types found in the embryonic and adult body in vivo, and can be induced to differentiate into many cell types under appropriate culture conditions in vitro. Using these properties, people have set up various differentiated systems of many cell types and tissues in vitro. Through analysis of these systems, one can identify novel bioactive factors and reveal mechanisms of cell differentiation and organogenesis. ES cell-derived differentiated cells can also be applied to cell transplantation therapy. In addition, we summarized the features and potential applications of human ES cells.     

Induction of embryonic stem cells to hematopoietic cells in vitro

In order to get hematopoietic cells from embryonic stem (ES) cells and to study development mechanisms of hematopoietic cells, the method of inducing embryonic stem cells to hematopoietic cells was explored by differenciating mouse ES cells and human embryonic cells in three stages. The differentiated cells were identified by flow cytometry, immunohistochemistry and Wright's staining. The results showed that embryoid bodies (EBs) could form when ES cells were cultured in the medium with 2-mercaptoethanol (2-ME). However, cytokines, such as stem cell factor (SCF), thrombopoietin (TPO), interleukin-3 (IL-3), interleukin-6 (IL-6), erythropoietin (EPO) and granular colony stimulating factor (G-CSF), were not helpful for forming EBs. SCF, TPO and embryonic cell conditional medium were useful for the differentiation of mouse EBs to hematopoietic progenitors. Eighty-six percent of these cells were CD34+ after 6-d culture. Hematopoietic progenitors differentiated to B lymphocytes when they were cocultured with primary bone marrow stroma cells in the DMEM medium with SCF and IL-6. 14 d later, most of the cells were CD34-CD38+. Wright's staining and immunohistochemistry showed that 80% of these cells were plasma-like morphologically and immunoglubolin positive. The study of hematopoietic cells from human embryonic cells showed that human embryonic cell differentiation was very similar to that of mouse ES cells. They could form EBs in the first stage and the CD34 positive cells account for about 48.5% in the second stage.     

胚胎干细胞及其在人类疾病治疗中的应用

胚胎干细胞是一类多能性干细胞,近年来已成为生命科学研究领域的热点之一．尤其在人类疾病治疗方面有着诱人的应用前景．本文主要介绍了胚胎干细胞在几种疑难疾病治疗上的应用及其前景,胚胎干细胞与异种器官移植。以及目前存在的一些问题．     

Anti-CD44 mAb remodels biological behaviors of spheroid cells with stemness from human ovarian cancer cell line SKOV-3

There is accumulating evidence that cancer stem cells (CSCs) play an important role in tumor progression. Novel strategies targeting CSCs have been widely researched. In the present study, we explored whether such CSCs existed in human ovarian cancer (OVCA) cell line and whether anti-CD44 antibody had effects on such subpopulation. We isolated and identified spheroid cells from SKOV-3. Then we used A3D8, an anti-CD44 mAb to treat spheroid cells with so-called stemness. Effects of A3D8 on spheroid cells’ biological behaviors were examined. Our findings showed that there was a small subpopulation that had so-called stemness in SKOV-3 cell line. Against spheroid cells, A3D8 can (1) inhibit cell proliferation; (2) change cell cycle distribution and expression of p21, CDK2 and cyclinA; (3) enhance cisplatin (DDP)-induced apoptosis; (4) promote cell differentiation; (5) inhibit clone formation efficiency; (6) reduce invasive efficacy; (7) inhibit tumorigenicity. Thus, to sum up points which we have just showed, spheroid cells isolated from SKOV-3 can be used as an appropriate in vitro model for relevant study of human ovarian CSCs. And our results reasoned that anti-CD44 therapy may become a potential promising strategy for OVCA treatment.     

基因打靶技术在实验动物中的研究进展

简要阐述了基因打靶的概念和基本环节 ,系统介绍了筛选方法和基因打靶的策略。基因打靶在基因功能研究、人类疾病动物模型的建立和基因治疗等方面有着广阔的应用前景     

胚胎干细胞向心肌细胞分化研究进展(综述)

胚胎干细胞(embryonic stem cells,ES)在体外分化培养条件下可以分化出各种组织细胞，其中包括心肌细胞。ES细胞在体外向心肌细胞分化与体内完整胚胎心肌发育过程相符合。该细胞在体外分化过程中顺序表达心肌细胞特有结构蛋白和离子通道，如肌球蛋白轻链和重链、特异性肌动蛋白、电压依赖性Ca^2 通道、K^ 通道等。ES细胞分化来源的心肌细胞具有体内心肌细胞的生理学特点，如产生的动作电位、表现自发性收缩等。因此，ES细胞是研究心肌细胞发育分化机制及鉴定其关键基因的理想模型。     

Induction of embryonic stem cells to hematopoietic cellsin vitro

In order to get hematopoietic cells from embryonic stem (ES) cells and to study development mechanisms of hematopoietic cells, the method of inducing embryonic stem cells to hematopoietic cells was explored by differenciating mouse ES cells and human embryonic cells in three stages. The differentiated cells were identified by flow cytometry, immunohistochemistry and Wright’s staining. The results showed that embryoid bodies (EBs) could form when ES cells were cultured in the medium with 2-mercaptoethanol (2-ME). However, cytokines, such as stem cell factor (SCF), thrombopoietin (TPO), interleukin-3 (IL-3), interleukin-6 (IL-6), erythropoietin (EPO) and granular colony stimulating factor (G-CSF), were not helpful for forming EBs. SCF, TPO and embryonic cell conditional medium were useful for the differentiation of mouse EBs to hematopoietic progenitors. Eighty-six percent of these cells were CD34⁺ after 6-d culture. Hematopoietic progenitors differentiated to B lymphocytes when they were cocultured with primary bone marrow stroma cells in the DMEM medium with SCF and IL-6. 14 d later, most of the cells were CD34^－CD38⁺. Wright’s staining and immunohistochemistry showed that 80% of these cells were plasma-like morphologically and immunoglubolin positive. The study of hematopoietic cells from human embryonic cells showed that human embryonic cell differentiation was very similar to that of mouse ES cells. They could form EBs in the first stage and the CD34 positive cells account for about 48.5% in the second stage.     

间质干细胞来源、鉴定、可塑性和应用前景(综述)

间质干细胞(MSCs)存在于骨髓、肌肉、骨、软骨等部位,可分化为中胚层的细胞,如成骨细胞、成软骨细胞、成脂肪细胞等,亦可分化为内胚层、外胚层的细胞,如神经细胞、肝脏细胞、肾脏细胞等,同时由于来源广、易于分离扩增和基因转染,在临床、科研上有很大的潜在应用价值。     

脂肪来源的间充质干细胞分离方法的改进

目的:从供体年龄、取材部位、提取方法3方面来研究稳定的脂肪间充质干细胞(ADMSCs)分离提取方法.方法: 从兔颈背部皮下、肌间以及腹股沟皮下的脂肪组织取材,分别采用一次消化收集法和多次消化收集法分离提取ADMSCs,单层传代培养.分别比较不同提取方法,老年兔、壮年兔与幼年兔,同一供体不同部位的脂肪组织,所分离的ADMSCs产量和生物学特性.结果: 运用多次消化收集法能从脂肪组织中稳定分离出生长旺盛的ADMSCs,与一次消化收集法相比能显著提高所获取的的细胞产量.从老年兔、壮年兔、幼年兔以及同一供体的不同部位脂肪组织中所提取的ADMSCs生长增殖活性无明显差异,但从单位体积脂肪组织提取得到的ADMSCs产量显著不同.结论: 多次消化收集法能显著提高分离获得的ADMSCs产量,是对传统的一次消化收集法的改进.选择不同供体年龄和取材部位提取ADMSCs,对细胞的生物学活性影响不大,但对细胞产量有明显影响.     

Differentiation of embryonic stem cells transfected by ibeB gene

We have previously identified an E. coli determinant, ibeB gene locus contributing to invasion of human brain microvascular endothelial cells. In the present study, we established embryonic stem (ES) cell lines overexpressing IbeB and found that exogenic ibeB gene could start-up expression of a neural stem cell specific marker, nestin, and give rise to polar changes. In analysis of IbeB location, it was found that GFP-IbeB fusion protein targeted at the ES cell nucleus. These data suggests that ibeB gene may play an important role in the regulation of nestin expression.     

神经干细胞及其临床应用潜能

近年来神经干细胞已在成年哺乳动物中的中枢神经系统中分离成功。神经干细胞的最基本特征是具有分化为神经元、星状胶质细胞和少突胶质细胞的潜能，具有自我更新能力，并足以维持整个大脑所需。神经干细胞在修复受伤神经组织及治疗神经系统退行性疾病，如帕金森病、阿尔茨海默病、和亨庭顿病等方面有很好的应用前景。但在达到临床实际应用之前仍有一系列问题需要解决，最首要的是搞清神经干细胞的分化机制。     

以整合素为靶点治疗乳腺癌的研究进展

乳腺癌是严重影响妇女身心健康甚至危及生命的最常见肿瘤之一,发病率占各种恶性肿瘤的7%～10%.乳腺癌通常发生于乳房腺上皮组织,绝经期前后的妇女发病率较高.男性乳腺癌罕见,仅占乳腺癌患者的1%～2%.整合素是细胞表面受体的主要家族,介导细胞和细胞外基质的黏附,介导细胞间的相互作用.整合素在生物体内广泛表达,在许多生命活动中发挥着关键的作用.整合素与癌症进程密切相关,在转移性肿瘤中某些整合素高表达,并与蛋白水解酶相互作用,导致基底膜降解.整合素通过重塑细胞外基质在肿瘤的迁移和侵袭中起着重要作用.综述了以整合素为靶点治疗乳腺癌的新进展.     

Gene transfer into primary cultures of fetal neural stem cells by a recombinant adenovirus carrying the gene for green fluorescent protein

Objective： To evaluate the transduction efficiency of a recombinant adenovirus carrying the gene for green fluorescent protein （Ad-GFP） into the primary cultures of fetal neural stem cells （NSCs） by the expression of GFP. Methods： The Ad-GFP was constructed by homologous recombination in bacteria with the AdEasy system; NSCs were isolated from rat fetal hippocampus and cultured as neurosphere suspensions. After infection with the recombinant Ad-GFP, NSCs were examined with a fluorescent microscopy and a flow cytometry for their expression of GFP. Results： After the viral infection, flow cytometry analysis revealed that the percentage of GFP-positive cells was as high as 97.05%. The infected NSCs sustained the GFP expression for above 4 weeks. After differentiated into astrocytes or neurons, they continued to express GFP efficiently. Conclusion： We have success- fully constructed a viral vector Ad-GFP that can efficiently infect the primary NSCs. The reporter gene was showed fully and sustained expression in the infected cells as well as their differentiated progenies.     

配对组合测试用例集生成的一种新策略

基于人工蜂群(ABC)算法与粒子群优化(PSO)算法,提出了一种新的配对混合人工蜂群(PHABC)策略,用于求解含约束条件的配对组合测试中测试用例集的生成问题.实验结果表明,即使在带有参数约束的情况下,PHABC输出的最佳组合测试集结果正确性更高,相较于其他现有的策略,性能更优.     

Therapeutic applications of bone marrow-derived stem cells in liver transplantation for end-stage liver diseases

Today, liver transplantation (LT) is the only established treatment for end-stage liver diseases. The de- velopment of LT, including OLT, cadaveric LT, split LT, living donor LT (LDLT), brings hopes to patients with these diseases. However, increasing donor shortage, rejection and life-long immunosuppression with its side effects are the major limitations of this therapy strategy. Bone marrow-derived stem cells (BMDSCs) are capable of differentiating into hepatocyte-like cells and contribute to liver injury repair. The microenvironment of liver injury caused by rejection, ischemia/reperfusion, loss of liver mass, recurrence of HCV and "small-for-size syndrome" after LT can attract a variety of bone marrow-derived stem cell population to the peripheral circulation and then migration to the injury liver to promote the hepatic function restoration. Additionally, BMDSCs can also take part in the functional regeneration of living donor liver after LDLT. This participation in liver regeneration may be associated to the interac- tion between SDF-1and its receptor CXCR4, involving HGF, IL-8, MMP9, and VEGF/VEGFR-2. BMDSC with its bio-characteristics could maintain the allograft tolerance from different angles and in different ways. In conclusion, BMDSCs transplantation, as a new assistant therapeutic method for LT, will ex- pand the space of LT, and provide more survival opportunities for the patients suffering liver diseases in the future.     

昆明鼠胚胎干细胞的分离培养与鉴定

目的：从昆明系小鼠的早期胚胎分离和培养胚胎干细胞(ES细胞)．方法：收集小鼠3．5d胚龄的囊胚，将其培养在小鼠胚胎成纤维细胞饲养层上，5—6d后取隆起生长的内细胞团块分离后再培养，观察集落的生长情况并通过碱性磷酸酶染色、原位杂交、细胞核型分析等对细胞集落进行鉴定．结果：KS细胞集落性生长，符合小鼠胚胎干细胞的一系列特性．结论：昆明系小鼠囊胚在胚胎成纤维细胞饲养层上可以发育成ES细胞，并能进行传代培养．     

人骨髓间充质干细胞不同亚群

目的 比较不同亚群的人骨髓间充质干细胞(human bone mesenchymal stem cell, hBMSC)自我更新和分化能力。方法 通过获赠的人髂骨骨髓标本,联合运用密度梯度离心和差异贴壁法分离MSCs , 用10μm 滤膜将不同群体细胞分离,倒置相差显微镜观察不同亚群细胞的形态;流式细胞仪检测BMSC不同亚群细胞的表型;在地塞米松、Vit C、β-磷酸甘油钠作用下将不同亚型细胞向成骨细胞诱导分化,分别观察其分化能力。结果 成熟的MSC,即mMSCs 细胞(mature cells)呈纤维样梭形, RS 细胞(rapidly MSC self-renewing cells)呈圆形。RS细胞增殖能力明显强于mMSCs。经定向诱导分化后,RS细胞向成骨细胞分化能力较mMSCs细胞强。结论 RS 细胞较之mMSC细胞可能是一种更原始的中胚层前体细胞,具有更强的自我更新和分化潜能。     

微囊化基质细胞对脐带血造血干/祖细胞扩增支持

将脐带血单个核细胞与包埋有兔骨髓间充质干细胞的海藻酸钙微胶珠在3种不同的培养液中进行了7d的体外静态共培养.每24h进行总有核细胞计数,在0、72和168h进行流式CD34+细胞分析以及甲基纤维素集落检验.实验结果表明:经过7d的静态共培养,在添加常规剂量造血生长因子的培养液中,总有核细胞扩增了(15±2.85)倍,CD34+细胞扩增了(5.33±0.32)倍,CFU-Cs扩增了(5.6±1.21)倍.微胶囊可以作为一种新的共培养隔离手段,微囊化兔骨髓间充质干细胞在添加适量血清或者造血生长因子组合的条件下对于脐带血造血干/祖细胞在静态下的扩增有明显的促进作用.